A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Korean South West Oncology Group.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Korean South West Oncology Group
ClinicalTrials.gov Identifier:
NCT01497041
First received: December 14, 2011
Last updated: December 19, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)